Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$6.4M Sell
86,988
-1,850
-2% -$136K 0.72% 33
2020
Q4
$6.93M Buy
88,838
+841
+1% +$64.3K 0.74% 34
2020
Q3
$6.96M Sell
87,997
-8,115
-8% -$636K 0.82% 31
2020
Q2
$7.69M Buy
96,112
+8,239
+9% +$620K 0.87% 32
2020
Q1
$6.45M Sell
87,873
-3,869
-4% -$304K 0.95% 28
2019
Q4
$7.96M Sell
91,742
-1,157
-1% -$95K 0.9% 30
2019
Q3
$7.46M Buy
+92,899
New +$7.45M 0.9% 30

Other funds holding MRK

TCF National Bank's MRK Position: Q1 2021 in Review

TCF National Bank reduced its Merck (MRK) stake by 2.1% in Q1 2021, selling an estimated $136K and leaving 86,988 shares worth $6.4M. The position accounts for 0.72% of the portfolio, ranked #33.

TCF National Bank first reported a position in MRK in Q3 2019 and has held it in 7 quarters since. The position peaked at $7.96M in Q4 2019. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • TCF National Bank held 86,988 shares of Merck worth $6.4M as of Q1 2021.
  • TCF National Bank sold 1,850 Merck shares in Q1 2021, an estimated $136K.
  • Merck made up 0.72% of TCF National Bank's portfolio in Q1 2021, its #33 holding.
  • TCF National Bank first reported a position in Merck in Q3 2019 and has held it in 7 quarters since.
  • TCF National Bank's Merck position peaked at $7.96M in Q4 2019.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.